172 related articles for article (PubMed ID: 21043491)
21. Total synthesis of bryostatin 1.
Keck GE; Poudel YB; Cummins TJ; Rudra A; Covel JA
J Am Chem Soc; 2011 Feb; 133(4):744-7. PubMed ID: 21175177
[TBL] [Abstract][Full Text] [Related]
22. Biological profile of the less lipophilic and synthetically more accessible bryostatin 7 closely resembles that of bryostatin 1.
Kedei N; Lewin NE; Géczy T; Selezneva J; Braun DC; Chen J; Herrmann MA; Heldman MR; Lim L; Mannan P; Garfield SH; Poudel YB; Cummins TJ; Rudra A; Blumberg PM; Keck GE
ACS Chem Biol; 2013 Apr; 8(4):767-77. PubMed ID: 23369356
[TBL] [Abstract][Full Text] [Related]
23. Photocatalytic Tandem Radical Cyclization Enables Expeditious Total Synthesis of Epoxyhinokiol Analogues for Anticancer Activity Evaluation.
Xiao J; Wu H; Liang JR; Wu P; Guo C; Wang YW; Wang ZY; Peng Y
Org Lett; 2024 May; 26(17):3481-3486. PubMed ID: 38240748
[TBL] [Abstract][Full Text] [Related]
24. Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review.
Raghuvanshi R; Bharate SB
Curr Top Med Chem; 2020; 20(12):1124-1135. PubMed ID: 32209043
[TBL] [Abstract][Full Text] [Related]
25. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
Szallasi Z; Du L; Levine R; Lewin NE; Nguyen PN; Williams MD; Pettit GR; Blumberg PM
Cancer Res; 1996 May; 56(9):2105-11. PubMed ID: 8616857
[TBL] [Abstract][Full Text] [Related]
26. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
Kumar VP; Chandrasekhar S
Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of the bryostatin 1 northern hemisphere (C1-C16) via desymmetrization by ketalization/ring-closing metathesis.
Voight EA; Seradj H; Roethle PA; Burke SD
Org Lett; 2004 Oct; 6(22):4045-8. PubMed ID: 15496095
[TBL] [Abstract][Full Text] [Related]
28. The practical synthesis of a novel and highly potent analogue of bryostatin.
Wender PA; Baryza JL; Bennett CE; Bi FC; Brenner SE; Clarke MO; Horan JC; Kan C; Lacôte E; Lippa B; Nell PG; Turner TM
J Am Chem Soc; 2002 Nov; 124(46):13648-9. PubMed ID: 12431074
[TBL] [Abstract][Full Text] [Related]
29. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
[TBL] [Abstract][Full Text] [Related]
30. Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications.
Wu R; Chen H; Chang N; Xu Y; Jiao J; Zhang H
Chemistry; 2020 Jan; 26(6):1166-1195. PubMed ID: 31479550
[TBL] [Abstract][Full Text] [Related]
31. Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro.
DeChristopher BA; Loy BA; Marsden MD; Schrier AJ; Zack JA; Wender PA
Nat Chem; 2012 Sep; 4(9):705-10. PubMed ID: 22914190
[TBL] [Abstract][Full Text] [Related]
32. Total synthesis and biological evaluation of (-)-apicularen A and its analogues.
Palimkar SS; Uenishi J; Ii H
J Org Chem; 2012 Jan; 77(1):388-99. PubMed ID: 22118352
[TBL] [Abstract][Full Text] [Related]
33. Trimethylene Methane Dianion Equivalent for the Asymmetric Consecutive Allylation of Aldehydes: Applications to Prins-Driven Macrocyclizations for the Synthesis of Bryostatin 1 and Analogues.
Wender PA; Luu-Nguyen QH; Sloane JL; Ranjan A
J Org Chem; 2022 Dec; 87(23):15925-15937. PubMed ID: 36378802
[TBL] [Abstract][Full Text] [Related]
34. Concise synthesis of the bryostatin A-ring via consecutive C-C bond forming transfer hydrogenations.
Lu Y; Krische MJ
Org Lett; 2009 Jul; 11(14):3108-11. PubMed ID: 19586066
[TBL] [Abstract][Full Text] [Related]
35. The design, computer modeling, solution structure, and biological evaluation of synthetic analogs of bryostatin 1.
Wender PA; DeBrabander J; Harran PG; Jimenez JM; Koehler MF; Lippa B; Park CM; Siedenbiedel C; Pettit GR
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6624-9. PubMed ID: 9618462
[TBL] [Abstract][Full Text] [Related]
36. The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues.
Wender PA; Hinkle KW; Koehler MF; Lippa B
Med Res Rev; 1999 Sep; 19(5):388-407. PubMed ID: 10502742
[TBL] [Abstract][Full Text] [Related]
37. Computer-guided design, synthesis, and protein kinase C affinity of a new salicylate-based class of bryostatin analogs.
Wender PA; Nakagawa Y; Near KE; Staveness D
Org Lett; 2014 Oct; 16(19):5136-9. PubMed ID: 25238583
[TBL] [Abstract][Full Text] [Related]
38. Total synthesis and initial biological evaluation of new B-ring-modified bryostatin analogs.
Wender PA; Horan JC; Verma VA
Org Lett; 2006 Nov; 8(23):5299-302. PubMed ID: 17078702
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and Cytoxicity of Sempervirine and Analogues.
Pan X; Yang C; Cleveland JL; Bannister TD
J Org Chem; 2016 Mar; 81(5):2194-200. PubMed ID: 26828413
[TBL] [Abstract][Full Text] [Related]
40. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
